Please login to the form below

Not currently logged in
Email:
Password:

GE’s Fraser Black joins BioCity Scotland as MD

Replaces Ian Webster at Scottish life sciences hub

Fraser Black has been appointed as managing director at BioCity Scotland – a life sciences hub based at an old MSD facility in central Scotland.

He joins from GE Life Sciences where he was global services solutions director, and takes over from Ian Webster who had been managing director at BioCity Scotland since its launch in January, 2012.

In his new role, Black will oversee the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community.

“In Newhouse, we have the resources and exceptional facilities to build a world class hub of successful life science businesses in the central belt of Scotland, and I believe the potential to add real value to the economy is enormous,” said Black. “This is the goal I will work towards as we collectively build the BioCity community here.”

Black had been at GE Life Sciences 2005 having previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.

“He brings business development experience honed in the international life sciences arena, as well as world-class team-building skills so we are in very good hands,” said Dr Louis Nisbet, BioCity Scotland chair.

9th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Limited

Lucid are specialists committed to delivering excellent medical education that changes clinical practice. Our confidence in understanding therapy areas, together...

Latest intelligence

UK life sciences minister George Freeman
Creating a 21st century life sciences ecosystem
The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation...
Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...
Online Physician Communities
How can pharma innovate in child and TYA cancer?
by Dr Tim Ringrose, M3 (EU)...